Maria Serena Fabbrini Selected Research

Saporins

1/2021	Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells.
1/2018	Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.
10/2017	Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions).
11/2016	Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.
1/2009	Saporin suicide gene therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Serena Fabbrini Research Topics

Disease

6	Neoplasms (Cancer) 01/2018 - 01/2009
1	Glioma (Gliomas) 01/2021
1	Virus Diseases (Viral Diseases) 10/2017
1	Lymphoma (Lymphomas) 02/2015
1	Melanoma (Melanoma, Malignant) 01/2009
1	Experimental Melanoma 01/2009

Drug/Important Bio-Agent (IBA)

5	SaporinsIBA 01/2021 - 01/2009
2	Immunotoxins (Immunotoxin)IBA 01/2018 - 02/2015
2	Ribosome Inactivating ProteinsIBA 01/2018 - 11/2010
2	AntibodiesIBA 01/2018 - 02/2015
2	Immunoglobulin FragmentsIBA 01/2018 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 11/2016 - 02/2015
1	PolyethyleneimineIBA 01/2021
1	NucleolinIBA 01/2021
1	Glycoside Hydrolases (Endoglycosidases)IBA 10/2017
1	RicinIBA 10/2017
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2016
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2016
1	AntigensIBA 02/2015
1	Differentiation AntigensIBA 02/2015
1	Single-Chain AntibodiesIBA 02/2015
1	LuciferasesIBA 01/2009
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 01/2009
1	LipofectamineIBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	methyl sulfateIBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2018 - 11/2010
1	Injections 01/2009